13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001447228
Total reported value
$291.3M
$291.3M
23 檔
330.5%
At the close of Q2 2025, Yiheng Capital Management, L.P. disclosed equity holdings valued at approximately $291.3M, spread across 23 reported holdings.
In Q2 2025, Yiheng Capital Management, L.P. displayed an active expansion posture, initiating 3 new positions and adding to 4 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | JD | Jd.com Inc-adr | Stock-Consumer Disc | 49.86% | +5.02% | +28.96% | |
| 2 | BILI | Bilibili Inc-sponsored Adr | Stock-Other | 21.17% | +5.11% | -17.28% | |
| 3 | NOAH | Noah Holdings Ltd-spon Ads | Stock-Other | 7.22% | -5.79% | — | |
| 4 | ULS | Ul Solutions Inc - Class A | Stock-Industrials | 5.52% | — | — | |
| 5 | EDU | New Oriental Educatio-sp Adr | Stock-Consumer Staples | 2.91% | +1.79% | — | |
| 6 | PLNT | Planet Fitness Inc - Cl A | Stock-Consumer Disc | 2.65% | — | — | |
| 7 | VSAT | Viasat Inc | Stock-Tech | 1.95% | — | — | |
| 8 | HTHT | H World Group Ltd-adr | Stock-Other | 1.49% | -2.42% | -24.27% | |
| 9 | AKRO | Akero Therapeutics Inc | Stock-Other | 1.44% | — | -73.02% | |
| 10 | RERE | Atrenew Inc | Stock-Other | 0.94% | -2.23% | — | |
| 11 | IVA | Inventiva SA - Adr | Stock-Other | 0.76% | — | — | |
| 12 | ACMR | Acm Research Inc-class A | Stock-Other | 0.65% | — | — | |
| 13 | VRDN | Viridian Therapeutics Inc | Stock-Other | 0.63% | +0.76% | — | |
| 14 | DNLI | Denali Therapeutics Inc | Stock-Other | 0.59% | — | — | |
| 15 | DBVT | Dbv Technologies Sa-spon Adr | Stock-Other | 0.54% | -0.58% | — | |
| 16 | KYMR | Kymera Therapeutics Inc | Stock-Other | 0.48% | -0.15% | — | |
| 17 | SVCO | Silvaco Group Inc | Stock-Other | 0.47% | +0.93% | +8.29% | |
| 18 | TAL | Tal Education Group- Adr | Stock-Consumer Staples | 0.28% | -1.25% | — | |
| 19 | API | Agora Inc-adr | Stock-Other | 0.18% | -0.12% | +177.05% | |
| 20 | BEAM | Beam Therapeutics Inc | Stock-Other | 0.11% | +0.03% | — | |
| 21 | YSG | Yatsen Holding Ltd-adr | Stock-Other | 0.08% | -0.04% | — | |
| 22 | GBIOGBX | Generation Bio Co | Stock-Other | 0.03% | — | +450.97% | |
| 23 | TOUR | Tuniu Corp-spon Adr | Stock-Other | 0.02% | -0.10% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ULS | Ul Solutions Inc - Class A | +5.5% | NEW | New buy |
| 2 | PLNT | Planet Fitness Inc - Cl A | +2.7% | NEW | New buy |
| 3 | VSAT | Viasat Inc | +2% | NEW | New buy |
| 4 | NOAH | Noah Holdings Ltd-spon Ads | +1.3% | — | Unchanged |
| 5 | EDU | New Oriental Educatio-sp Adr | +0.3% | — | Unchanged |
| 6 | IVA | Inventiva SA - Adr | +0.2% | — | Unchanged |
| 7 | KYMR | Kymera Therapeutics Inc | +0.2% | — | Unchanged |
| 8 | DBVT | Dbv Technologies Sa-spon Adr | +0.1% | — | Unchanged |
| 9 | API | Agora Inc-adr | +0.1% | +177.05% | Add |
| 10 | RERE | Atrenew Inc | +0.1% | — | Unchanged |
| 11 | ACMR | Acm Research Inc-class A | 0% | — | Unchanged |
| 12 | SVCO | Silvaco Group Inc | 0% | +8.29% | Add |
| 13 | YSG | Yatsen Holding Ltd-adr | 0% | — | Unchanged |
| 14 | GBIOGBX | Generation Bio Co | 0% | +450.97% | Add |
| 15 | VRDN | Viridian Therapeutics Inc | — | — | Unchanged |
| 16 | DNLI | Denali Therapeutics Inc | — | — | Unchanged |
| 17 | TOUR | Tuniu Corp-spon Adr | 0% | — | Unchanged |
| 18 | BEAM | Beam Therapeutics Inc | 0% | — | Unchanged |
| 19 | TAL | Tal Education Group- Adr | -0.1% | — | Unchanged |
| 20 | JD | Jd.com Inc-adr | -0.4% | +28.96% | Add |
| 21 | HTHT | H World Group Ltd-adr | -0.7% | -24.27% | Trim |
| 22 | RBLX | Roblox CORP -class A | -1.5% | EXIT | Sold out |
| 23 | BILI | Bilibili Inc-sponsored Adr | -2.4% | -17.28% | Trim |
| 24 | AKRO | Akero Therapeutics Inc | -2.7% | -73.02% | Trim |
| 25 | ALAB | Astera Labs Inc | -4.6% | EXIT | Sold out |
According to official SEC Form 13F filings, Yiheng Capital Management, L.P. reported a total U.S. public equity portfolio value of $291.3M across 23 disclosed positions in Q2 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including JD, BILI, NOAH) accounted for 330.5% of total reported equity market value during Q2 2025.
Top New Position Initiated
ULS
市值: $61.3M
Top Position Liquidated / Trimmed
ALAB
前期市值: $49.9M
During Q2 2025, Yiheng Capital Management, L.P.'s top holdings by market value included JD (49.9%)、BILI (21.2%)、NOAH (7.2%). The largest single position, JD, represented 49.9% of total portfolio value.
In Q2 2025, Yiheng Capital Management, L.P. made 12 total portfolio adjustments, initiating 3 new buys, adding to 4 positions, trimming 3 holdings, and fully liquidating 2 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.